Drug
Bhv 1300
Bhv 1300: highest development phase Phase 3, developed by Biohaven Therapeutics Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biohaven Therapeutics Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| BHV-1300 NCT07661056 | Phase 3 | Graves Disease |
Latest
No recent events.
Follow Bhv 1300 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.